----

----

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

|   | (a) | Product      supplied hereunder shall be supplied as specified in PRECISION DOSE's      purchase orders made pursuant to this Article 2 and shall meet the      Product Specifications. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | Each      shipment shall be accompanied by a Certificate of Analysis in      English. |
|--------|-----|---------------------------------------------------------------------------------------|

|   | (c) | Product      shall be manufactured in accordance with cGMP and all other applicable      Laws and any procedures set forth in the Product Specifications and      Quality Agreement, and such additional procedures as may be agreed upon in      writing by the parties. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

|   |  (d) | Product      shall be purchased by PRECISION DOSE under this Agreement at the prices      set forth on Exhibit A attached      hereto. |
|--------|-----------|----------------------------------------------------------------------------------------------------------------------------------------|

|   | (a) | From      time to time and subject to the other provisions of this Agreement,      PRECISION DOSE shall place orders for Batch quantities of Product,      specifying delivery dates.  Subject to the terms of this      Agreement, ELITE shall meet specified delivery dates, provided the      delivery dates specified in any such orders shall not be less than ninety      (90) days from the date of suchorders. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | ELITE      shall use commercially reasonable efforts to accommodate a PRECISION DOSE      request for delivery of the Product sooner than as otherwise is required      under this Agreement;  and, if PRECISION DOSE’s business      conditions necessitate reduction of Product amount ordered or delay in      purchase order shipment dates, then ELITE shall use commercially      reasonable efforts to implement such requested changes, provided that, if      such changes cause ELITE to incur additional expenses, ELITE shall specify      such additional expenses in writing and provide such substantiating      documentation reasonably requested by PRECISION DOSE, and PRECISION DOSE      shall pay such additional expenses as and when  incurred. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (a) | Within      fifteen days (15) business days of the Effective Date, PRECISION DOSE will      provide ELITE with a written forecast of its requirements for the {***}      {***}mg Tablet for the next twelve (12)months. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | During      each successive calendar quarter, on or about the first day of that      quarter, PRECISION DOSE shall provide ELITE with a twelve (12) month      rolling forecast of the quantity of Product required by PRECISION DOSE, by      month, for the following twelve (12) months (each, a "Forecast"). |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

|   | (c) | It      is agreed by the parties that the first three (3) months of the twelve      (12) month forecast are binding on PRECISION DOSE.  It is      understood that such Forecasts for the remaining nine (9) months are      intended to be good faith estimates only, and shall not be binding upon      PRECISION DOSE.  PRECISION DOSE agrees that in the event this      Agreement is terminated by PRECISION DOSE or through the fault of      PRECISION DOSE, then PRECISION DOSE shall compensate ELITE for its cost      for any pharmaceutical or packaging materials purchased by ELITE to meet      any unused balance of the first three (3) months of the most recent twelve      (12) month Forecast provided by PRECISION DOSE to  ELITE. |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (d) | To      the extent that Product orders specified for shipment in any quarter      exceed the most recent PRECISION DOSE Forecast for such quarter by more      than ten percent (10%) (any excess of ten percent (10%) or less      shall, for this purpose, be deemed not to exceed forecast), ELITE shall      use its commercially reasonable efforts to fulfill any such excess      contained in PRECISION DOSE's Product orders, but ELITE shall not be      liable to PRECISION DOSE for any inability, despite its reasonable      efforts, to fill orders in excess of such  forecast. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (a) | Shipments      of Product shall be made from ELITE's Facility unless otherwise mutually      agreed to in writing by the parties.  Risk of loss or of damage      to the Product shall remain with ELITE until such Product is loaded onto      the carrier's vehicle in the United States by ELITE for shipment at the      shipping point at which time risk of loss or damage shall transfer to      PRECISION DOSE.  ELITE shall, in accordance with PRECISION      DOSE's instructions and as agent for PRECISION DOSE, arrange for shipping      to be paid by PRECISION DOSE.  PRECISION DOSE shall arrange for      insurance and shall select the freight carrier used by ELITE to ship the      Product and may monitor ELITE's shipping and freight practices as they      pertain to this Agreement.  Product shall be transported in      accordance with the Product Specifications and other applicable      Laws. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | To      accommodate production variances, a Batch quantity Product order shall be      considered filled by Elite if the amount shipped is at least 97.5% of the      quantity specified for a Batch in ExhibitA. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

|   | (a) | The      price for Product may be increased by ELITE for any orders placed after      the 12 month anniversary of the (1) first shipment of the Product subject      to the price increase by ELITE to PRECISION DOSE or (2) the effective date      of the previous price increase of such Product, whichever is later,      hereinafter “Adjustment      Date”.  In such an event, ELITE will propose an increase      to be reviewed and discussed with PRECISION DOSE at least 90 days prior to      the Adjustment Date. Any proposed increase shall not exceed the increase      in the United States Producers' Price Index, Pharmaceuticals      Preparations, NAICS      325412, during the period since the last increase, under this      Section 3.2 unless due to active pharmaceutical ingredient (API)      increases documented by the supplier invoices.  PRECISION DOSE      and ELITE recognize the competitive nature of the generic business and any      proposed price increases will be discussed in the context of the current      market environment at that time. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | The      price for the Product may be decreased.  Just as increases in      the material or component costs allow an increase in the Product cost, the      parties agree that reductions in the material or component cost shall      similarly reduce the price of the product charged by ELITE to PRECISION      DOSE.  To monitor changes in production costs, ELITE shall      deliver to PRECISION DOSE a Production Report on a quarterly      basis.   ELITE shall reduce the Product price upon downward      cost trends so that Product manufacturing cost savings are shared equally      by ELITE and PRECISION DOSE. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

|   | (c) | The      parties acknowledge the highly competitive nature of generic drugs and      that a situation might arise where ELITE cannot produce a Product at a      cost low enough for PRECISION DOSE to profitably sell that      Product.  In such event, at the discretion of ELITE and after      consultation with PRECISION DOSE, ELITE will supply the Product from      another supplier that is able to provide the Product to PRECISION DOSE for      significantly less (defined as greater than 10 percent) than the amount      which ELITE can provide the Product to PRECISION DOSE. PRECISION DOSE will      support such a transfer, and ELITE will provide the necessary technical      support for transfer of the Product manufacturing (including analytical      methods transfer) to a 3rd      party contract manufacturer. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

|   | (a) | Nonconformance.      If PRECISION DOSE discovers any nonconformance (“Nonconformance”) of      Product under this Agreement, PRECISION DOSE shall give prompt written      notice to ELITE specifying theNonconformance. |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

|   | (b) | Procedure for      Nonconformance.  Upon notifying ELITE of any      Nonconformance of Product PRECISION DOSE shall afford ELITE a reasonable      opportunity to inspect the Product in question and make an appropriate      adjustment or replacement.  The parties shall submit any dispute      regarding quality of the Nonconformance of Product to a mutually selected      independent laboratory, the determination of which shall be binding on the      parties and the costs of which shall be borne by the party against whom      such determination is rendered.  If such laboratory confirms a      Nonconformance of the Product in question (or any part of it) at the time      of delivery to the carrier, or if the parties agree that there is a      Nonconformance, then, in addition to other remedies that may be available,      ELITE shall promptly refund or provide a credit for any money paid by      PRECISION DOSE (including shipping costs) with respect to such      Nonconforming Product. ELITE may, at its sole option, either direct      PRECISION DOSE to return nonconforming Product to ELITE or have it      destroyed by PRECISION DOSE, and certify such destruction to ELITE, all at      ELITE’s expense. |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (a) | ELITE's      and/or its Affiliates', subcontractors' or suppliers' failure to comply      with the Product Specifications, cGMP or applicable  Laws; |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | the      storage, distribution or handling of the Product after the Effective Date      by ELITE or any third party, other than a third party acting on behalf of      PRECISION DOSE or its Affiliates, including, without limitation, any      carrier delivering the Product; |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (c) | any      breach of any representation, warranty, covenant or similar promise made      under this Agreement or arising out of this  Agreement; |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (d) | any      negligence or willful misconduct by ELITE and/or any of its employees;      and |
|--------|-----|------------------------------------------------------------------------------------------|

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

|   | (e) | for      any Product that is recalled or withdrawn from the market by reason of      ELITE’s breach of any warranty or other covenant under this Agreement or      any other agreement with PRECISION DOSE, PRECISION DOSE will be entitled      to reimbursement of all costs associated with a recall or withdrawal,      including the cost of the Product, and reasonable costs associated with      compliance with the recall or withdrawal (including      penalties).  If it is determined that the recall or withdrawal      should extend to the Product packaged into unit dose or distributed by      PRECISION DOSE, then reimbursement to PRECISION DOSE will be extended to      include all its expenses of compliance, including manufacturing and      packaging costs and materials, return fees, distributor reimbursement,      processing expense such as customer notification and returns, shipping,      disposal and penalty costs associated with the product of the recalled or      withdrawn lots only. |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (a) | the      use, marketing, storage, distribution, handling or sale of the Product      after the Effective Date by PRECISION DOSE or any third party, other than      a third party acting on behalf of ELITE or its  Affiliates; |
|--------|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | any      product liability in connection with the Products caused by PRECISION DOSE      or any third party acting on behalf of PRECISION DOSE or its      Affiliates; |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (c) | any      liabilities arising out of the presence or actions of a PRECISION DOSE      employee at the Facilities pursuant to this Agreement;  and |
|--------|-----|--------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (d) | any      negligent or wrongful act by PRECISION DOSE and any breach by PRECISION      DOSE of any representation or warranty, covenant or similar promise made      under this Agreement or arising out of this  Agreement. |
|--------|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

| If      to ELITE:    | Elite      Pharmaceuticals, Inc.         |
|----------------------|------------------------------------------|
|                 | 165      Ludlow Avenue                   |
|                 | Northvale,      NJ 07647                 |
|                 | Attention:  President          |
|                 | Facsimile:      201-750-2755             |
|                 |                                     |
| with      a copy to: | Richardson      & Patel              |
|                 |                                     |
|                 | Murdock      Plaza                       |
|                 | 10900      Wilshire Boulevard, Suite 500 |

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

|                       | Los      Angeles, California 90024                    |
|----------------------------|-------------------------------------------------------|
|                       | Attention:      Kevin Friedmann                       |
|                       | Facsimile:      310-208-1154                          |
|                       |                                                  |
| If      to PRECISION DOSE: | Precision      Dose, Inc.                             |
|                       | 722      Progressive Lane                             |
|                       | South      Beloit, IL  61080                |
|                       | Attention:  President                       |
|                       | Facsimile:      815-624-8245                          |
|                       |                                                  |
| with      a copy to:       | Reilly      Law Offices                               |
|                       | 6801      Spring Creek Rd., Suite 2D                  |
|                       | Rockford,      IL 61114                               |
|                       | Attention:  William      A. Reilly II, Esq. |
|                       | Facsimile:      815-316-8545                          |

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

| ELITE      PHARMACEUTICALS, INC. |            | PRECISION      DOSE INC. |
|----------------------------------|-----------------|--------------------------|
|                             |            |                     |   |   |
| By:                              |       |                     | By: |   |
| Name:                       | Chris      Dick |                     | Name:  | Robert      Koopman |
| Title:                           | President       |                     | Title: | President |

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

| Product                    |         | Mg      |         | BottleSize  |         | BatchSize |         | BottlesPerBatch |         | BatchCost |         | Cost PerBottle |         | Label            |
|----------------------------|--------------|---------|--------------|-------------|--------------|-----------|--------------|-----------------|--------------|-----------|--------------|---------------------|--------------|------------------|
| Hydromorphone      Tablets |         | 8mg     |         | 100's       |         | {***}     |         | {***}           |         | ${***}*   |         | ${***}*             |         | TAGI      Pharma |
| Hydromorphone      Tablets |         | 4mg     |         | 100's       |         | {***}     |         | {***}           |         | ${***}*   |         | ${***}*             |         | TAGI      Pharma |
| Hydromorphone      Tablets |         | 2mg     |         | 100's       |         | {***}     |         | {***}           |         | ${***}*   |         | ${***}*             |         | TAGI      Pharma |
| Hydromorphone      Tablets |         | 8mg     |         | 500’s |         | {***}     |         | {***}           |         | ${***}*   |         | ${***}*             |         | TAGI      Pharma |
| Hydromorphone      Tablets |         | 4mg     |         | 500’s |         | {***}     |         | {***}           |         | ${***}*   |         | ${***}*             |         | TAGI      Pharma |
| Hydromorphone      Tablets |         | 2mg     |         | 500’s |         | {***}     |         | {***}           |         | ${***}*   |         | ${***}*             |         | TAGI      Pharma |
| Naltrexone      Tablets    |         | 50mg    |         | 30's        |         | {***}     |         | {***}           |         | ${***}    |         | ${***}              |         | TAGI      Pharma |
| Naltrexone      Tablets    |         | 50mg    |         | 100's       |         | {***}     |         | {***}           |         | ${***}    |         | ${***}              |         | TAGI      Pharma |
| {***}Tablets               |         | {***}mg |         | 100's       |         | {***}     |         | {***}           |         | ${***}    |         | ${***}              |         | TAGI      Pharma |
| {***}Tablets               |         | {***}mg |         | 1,000's     |         | {***}     |         | {***}           |         | ${***}    |         | ${***}              |         | TAGI      Pharma |
| {***}Capsules              |         | {***}mg |         | 100's       |         | {***}     |         | {***}           |         | ${***}    |         | ${***}              |         | TAGI      Pharma |
| {***}Capsules              |         | {***}mg |         | 1,000's     |         | {***}     |         | {***}           |         | ${***}    |         | ${***}              |         | TAGI      Pharma |
| {***}Capsules              |         | {***}mg |         | 100's       |         | {***}     |         | {***}           |         | ${***}    |         | ${***}              |         | TAGI      Pharma |
| {***}Capsules              |    | {***}mg |    | 1,000's     |    | {***}     |    | {***}           |    | ${***}    |    | ${***}              |    | TAGI      Pharma |

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

----

| ELITE      and Precision Dose           |                   |
|-----------------------------------------|------------------------|
| Manufacturing      and Supply Agreement | Execution      Version |

----

| This      Exhibit C to the Manufacturing and Supply Agreement (the “Supply      Agreement”) defines the responsibilities for all current Good      Manufacturing Practice (cGMP) activity relating to manufacturing,      packaging, storing, and testing the      identified  Product(s).    The above      mentioned parties hereto mutually agree to the following      requirements. |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 1.     | SCOPE                                                                                                                                                                                                                                                                                                                   |
|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | This      Exhibit C defines the requirements related to the manufacturing,      packaging, quality control, release and stability testing for Products      manufactured by ELITE.  These requirements are intended to      ensure compliance with current cGMP guidelines and other regulatory      requirements. |

| 2. | DEFINITIONS      AND ABBREVIATIONS |
|----|------------------------------------|

|   | ANDA | Abbreviated      New Drug Application |
|--------|------|---------------------------------------|

|   | APR | Annual      Product Review |
|--------|-----|----------------------------|

|   | C      of A | Certificate      of Analysis |
|--------|-------------|------------------------------|

|   | C      of C | Certificate      of Conformance |
|--------|-------------|---------------------------------|

|   | CFR | Code      of Federal Regulations |
|--------|-----|----------------------------------|

|   | cGMP | Current      Good Manufacturing Practice |
|--------|------|------------------------------------------|

|   | DEA | Drug      Enforcement Agency |
|--------|-----|------------------------------|

|   | DMF | Drug      Master File |
|--------|-----|-----------------------|

|   | FDA | Food      & Drug Administration |
|--------|-----|-------------------------------------|

|   | HS&E | Health,      Safety & Environment |
|--------|----------|---------------------------------------|

|   | HVAC | Heating,      Ventilation, and Air Conditioning |
|--------|------|-------------------------------------------------|

|   | IND | Investigational      New Drug |
|--------|-----|-------------------------------|

|   | May | Indicates      that a provision is optional and is used for conditional      issues |
|--------|-----|-------------------------------------------------------------------------------------|

|   | MSDS | Material      Safety Data Sheets |
|--------|------|----------------------------------|

|   | Must | Indicates      a provision that is compulsory, such as  regulations |
|--------|------|---------------------------------------------------------------------|

|   | NDA | New      Drug Application |
|--------|-----|---------------------------|

|   | OOS | Out      of Specification |
|--------|-----|---------------------------|

|   | Shall | Indicates      a provision that is binding |
|--------|-------|--------------------------------------------|

|   | Will | Indicates      a provision of intent, but not necessarily an  obligation |
|--------|------|--------------------------------------------------------------------------|

----

| 3.     | PRODUCT                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | The      Product that is covered by this Exhibit C is included in Appendix      2.  A separate Appendix is or will be provided for each      additional Product.  As drugs and services are added or removed,      Appendices may be added or deleted with the written approval of ELITE and PRECISION      DOSE.                                                                                                                                      |
| 4.     | MANUFACTURE                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 4.1    | Premises                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|   | 4.1.1         Operations                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|   | ELITE will manufacture      the Product at its Northvale, New Jersey Plant as specified by this      Exhibit C and will not use or transfer at a later date any of the      manufacturing or testing operations for the Product to an alternate site      without the prior written notification to PRECISION      DOSE.                                                                                                                                                   |
|   | 4.1.2         Compliance                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|   | The      premises and equipment used for manufacture must be in compliance with      Product Specifications and approved aNDA, cGMPs,  and current      regulatory requirements.                                                                                                                                                                                                                                                                                      |
|   | 4.1.3    Security                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|   | ELITE will maintain      controlled access to the premises.  For example, additional      security measures may be required for DEA products, per current      regulations.  All visitors must sign in and be escorted during      any visit to the areas of the premise used to manufacture, test, and store      the Product.                                                                                                                             |
|   |          4.1.4    Confidentiality                                                                                                                                                                                                                                                                                                                                                                                                            |
|   | ELITE and PRECISION DOSE      will protect the confidentiality of the processes and documents      related to the Product.  The obligations of confidentiality      shall be continuing and shall survive the expiration or termination of the      Agreement and this Exhibit C and/or any attachments hereto for a period of      five years.                                                                                                                       |
|   | 4.1.5         Personnel                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|   | ELITE shall employ an      adequate number of trained personnel to support the manufacture of      Product(s) according to cGMP requirements.  Each person engaged      in the manufacture, processing, packaging, or holding of a drug product      shall have education, training, and experience, or a combination thereof,      to enable that person to perform the assigned functions in a competent and      efficient manner.  (CFR 21 Sec. 211.25) |
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |

----

|                                                        | 4.1.6         Health, Safety, and Environment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|-------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                        | ELITE commits to operate      within all current HS&E legislation at sites that manufacture      products.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 4.2        GMP      Guidelines               |
|                                                        | The      cGMP guidelines to be applied are the United States cGMPs listed in 21      Code of Federal Regulations (CFR) Parts 11 Electronic Records, 200, 210,      and 211 and associated Compliance Guidances.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 4.3         IND/NDA/ANDA/OTC/           |
|                                                        | The      Product(s) must be manufactured as specified in the manufacturing formula      within the approved Investigational New Drug/New Drug      Application/Abbreviated New Drug Application (IND/NDA/ANDA) or approved      internal documents. If ELITE makes any changes      to these methods, that require a supplement to the application, written      notification will be given to PRECISION      DOSE.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 4.4         Specifications              |
|                                                        | Manufacturing      Batch Records and Testing Protocols will be prepared according to      Specifications as defined in the Supply Agreement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 4.5         Subcontractors         |
|                                                        | ELITE is responsible for      auditing the quality systems of a potential subcontractor and agrees to      demonstrate due diligence during the audit process. PRECISION DOSE retains      the right to audit such contractors. Subcontractors approved for a portion      of the manufacturing and packaging tasks shall be audited by either party      on an annual basis, with such audits alternating between the parties each      year. If critical deficiencies are found, the parties (PRECISION DOSE, ELITE      and subcontractor) shall meet promptly to discuss and resolve them and      PRECISION DOSE      shall be entitled to make reasonable follow up inspections (as much as      semi-annual) to monitor the correction of the deficiencies. All other      subcontractors will be audited on a bi-annual basis. ELITE must not      subcontract any aspects of the Manufacture of the Product to a third party      without prior notification and approval of PRECISION DOSE. ELITE shall be      responsible for complete supervision and control over every      subcontractor.  All subcontractors shall be directly responsible      to ELITE and shall      be subject in all respects to the provisions of the Agreement and all      attachments including this Exhibit C. Nothing contained in the Supply      Agreement and this Exhibit C or any attachment shall create any      contractual relationship between any subcontractor and PRECISION DOSE. Further,      any subcontractor of services shall not relieve ELITE from full      responsibility for the work or for the fulfillment of all obligations      under the Supply Agreement or this Exhibit C or any attachment      hereto. |

----

| 4.6         Materials                                   |
|-----------------------------------------------------------------------------|
|                                                                        | 4.6.1         Materials      Procured by ELITE   |
|                                                                        | ELITE      is responsible for ensuring that all materials procured by and for use in      the Product(s) are in full compliance with the approved      specifications.  Each incoming batch of components shall be      assigned a unique identity or control number and inspected according to      incoming testing protocols.  |
|                                                                        | 4.6.2         Potential      Contaminants  |
|                                                                        | ELITE must inform PRECISION DOSE of any      highly sensitizing material, infectious agents, high pharmacological      activity or toxicity materials (e.g., penicillin, hormones, and      cephalosporin), herbicides, or pesticides that are handled by ELITE at the same      site.  |
| 4.7         Labeling                                    |
|                                                                        | 4.7.1         Content  |
|                                                                        | PRECISION      DOSE is responsible for      all accuracy of the information contained in all PRECISION      DOSE labeling and will      comply with all regulatory standards. PRECISION DOSE is responsible for providing      ELITE with all      related artwork/mock-ups for the Products. ELITE is responsible for the      submission of the labeling, in Structured Product Labeling format to the      application.  |
|                                                                        | 4.7.2         Procurement  |
|                                                                        | ELITE will procure all required      labeling that must be created according to the labeling specifications      of PRECISION DOSE      labeled product.  |
|                                                                        | 4.7.3.         Label      Development / Changes  |
|                                                                        | ELITE is responsible for      maintaining the labeling as current to the approved      application.  ELITE shall notify PRECISION DOSE of any      proposed changes to the labeling in sufficient time to allow PRECISION DOSE to make      the necessary changes.  |
| 4.8         Manufacturing/Packaging      Documentation  |
|                                                                        | 4.8.1         Licenses  |
|                                                                        | ELITE shall maintain a      current Manufacturing License and DEA License as required to manufacture      and package the Product(s).  |
|                                                                        | 4.8.2         Master      Documents  |
|                                                                        | ELITE shall develop and      control all master documentation relative to the manufacture, packaging,      and testing of the Product(s).  Any changes to the master      documentation that require a supplement to the application will require      PRECISION DOSE’s      written approval. |

----

|                                                         | 4.8.3         Executed      Batch Records                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|--------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                         | ELITE shall keep records      of the manufacture, testing and shipping of the Product, to comply with      the Product Specifications and all manufacturing regulatory requirements      and Laws applicable to ELITE, as well as to      assist with resolving Product complaints and other similar      investigations.  Copies of such records and samples shall be      retained according to a record retention procedure and for a period of      five (5) years following the date of Product(s) expiry or longer if      required by applicable Law, after which ELITE may destroy such      records.  |
| 4.9         Sterile      Product    |
|                                                              | Not      Applicable.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 4.10Batch      Numbering                           |
|                                                         | ELITE batch numbering      system will be used to uniquely number each batch of      Product(s).  This number will appear on all documents relating      to a particular batch of Product(s).                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 4.11Date      of Manufacture                       |
|                                                              | ELITE shall assign the      Date of Manufacture as the first day the active ingredient is added to the      process.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 4.12Expiration      Dating                         |
|                                                         | ELITE shall assign the      expiration date according to ELITE standard      procedures, which calculate the expiry date from the Date of Manufacture,      or date of filling, plus the Shelf life.  The expiration date      shall be formatted as month/year.                                                                                                                                                                                                                                                                                                                                               |
| 4.13Manufacturing      and Equipment Data          |
|                                                         | 4.13.1         Equipment      Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|                                                         | ELITE is responsible for      maintaining records of equipment usage, cleaning, service and maintenance,      raw material batch numbers and certification, in process results and      parameters, and previous Product(s) used in machinery, if non-dedicated      machinery is used.  Only equipment that has been validated,      calibrated, or qualified shall be used.                                                                                                                                                                                                                                  |
|                                                         | 4.123.2         Specifications                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                         | ELITE must produce and      package the Product(s) as specified in the      approved  manufacturing process, using the equipment and      procedures specified in the ANDA,  approved internal document      and/orDMF.                                                                                                                                                                                                                                                                                                                                                                                   |

----

| 5.0          QUALITY      ASSURANCE  |
|---------------------------------------------------------------|
| 5.1         Laboratories                  |
|                                                          | 5.1.1         Compliance      and Equipment  |
|                                                          | ELITE shall be      responsible for ensuring that all laboratories are compliant with relevant      cGMPs and GLP’s, and personnel and test methods are properly validated      and/or qualified for all of the methodology associated with      Product(s).  |
|                                                          | ELITE shall be      responsible for ensuring that all test equipment is properly maintained      and calibrated and that appropriate qualification has been      conducted.  |
|                                                          | 5.1.2         Laboratory      Methods  |
|                                                          | ELITE will ensure that      all components and in-process release testing used to manufacture the      Product(s) meets the specifications.  At least one test (ID) to      verify the identity of each batch of incoming material will be      conducted.  A supplier C of A or C of C may be referenced      instead of performing other tests, provided that a supplier evaluation      program is in force.  ELITE’s internal Quality      unit will approve all test results.  |
|                                                          | 5.1.3         Out      of Specification (OOS) Procedure  |
|                                                          | ELITE is responsible for      investigating any test result or in-process test that fails to meet      specification, in accordance with the current ELITE approved OOS      Procedures. ELITE      must notify PRECISION      DOSE of any confirmed OOS for its Product(s) within 24 hours of the      OOS identification, and ELITE will provide PRECISION DOSE with a      report of all OOS instances on a quarterly basis.  |
| 5.2         Release      Procedures       |
|                                                          | 5.2.1         Release      for Distribution  |
|                                                          | ELITE is responsible for      bottled product release for distribution - however, at the time of      shipment ELITE      must provide PRECISION      DOSE with the Certificate of Analysis used in the release of the      Product(s).  |

----

|                                                                  | 5.2.2       Product      Rejection Upon Receipt                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|-----------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                  | PRECISION      DOSE shall notify ELITE in writing of any claim relating to any Product(s)      that fails to meet the Product specifications no later than fifteen (15)      days of receipt of the Product(s) except where such failure to meet the      Product specification could not be reasonably known at the time of      receipt; in which case a fifteen (15) day period      commences.  PRECISION DOSE  shall be deemed to have      accepted the Product if it does not provide ELITE written notice of such      failure.  Both      parties may share information and agree on action plans including further      testing/analysis to resolve the situation.  PRECISION      DOSEandELITEshall      mutually work together on final disposition and payment of any rejected      Product.  |
| 5.3          Documentation                        |
|                                                                  | 5.3.1         Certificate      of Analysis/Certificate of Conformance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|                                                                  | All      deliveries of the Product(s) to PRECISION DOSE shall be      accompanied by the full C of A with the results of the analytical testing      by ELITE’s quality      control department and the confirmation that the Product(s) has/have been      manufactured and tested in accordance with cGMP requirements and complies      with the requirements of the Governmental Approval(s) and with the      Specifications, as set forth in Exhibit  C of the Supply      Agreement.  [However, such C of A and Confirmation shall be      pre-shipped before delivery of the Product(s).]                                                                                                                                                                                                                        |
| 5.4          Retained      Samples           |
|                                                                  | 5.4.1         Sample      Types                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                  | ELITE shall retain      adequate representative samples of each batch or lot of the Product(s), of      raw material, and of components used in the Manufacture of the Product(s).      (21 CFR Part 211.170a)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|                                                                  | 5.4.2    Annual      Retain Reviews                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                  | On      an annual basis, representative samples of retained lots will be inspected      visually according to ELITE’s      procedures.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 5.5         Stability      Protocols and Testing  |
|                                                                  | ELITE shall maintain a      stability program. Analysis of stability samples that do not meet      specification are subject to the process outlined in section 5.1.3 Out of      Specification (OOS) Procedures.  In the event that any batch of      Product fails stability testing, ELITE shall notify PRECSISION DOSE within      24 hours of the confirmed failure.                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

----

| 5.6         Audits                              |
|---------------------------------------------------------------------|
|                                                                | 5.6.1         Facility      Audit  |
|                                                                | Upon      prior notification to ELITE and within normal      working hours, PRECISION      DOSE is entitled to perform an annual quality inspection of the      facilities connected with the manufacture of the      Product(s).  Such representatives will be allowed to access all      relevant premises and facilities and to witness the manufacture of the      Product(s) in all its aspects to satisfy itself of the compliance of ELITE to the      Governmental Approval(s) with respect to the manufacture of the Product(s)      and compliance with cGMP regulations.  If deficiencies are      found, the parties shall meet promptly to discuss and resolve them and      PRECISION DOSE      shall be entitled to make reasonable follow up inspections (as often as      quarterly) to monitor the correction of the deficiencies  |
|                                                                | 5.6.2    Regulatory      Audit/Inspection  |
|                                                                | ELITE shall permit any necessary      inspection by the competent Authorities at the premises of manufacture,      including subcontractor sites.  Any such inspection by the      competent authorities which has potential to impact any Product(s) will be      promptly notified to PRECISION DOSE in      writing, and ELITE      shall immediately inform PRECISION DOSE in      writing of general and specific findings of the Authorities related to the      manufacture or testing of the Product(s) and or quality      systems.  |
| 5.7         Recall/Field      Alert/Complaints  |
|                                                                | 5.7.1         Recalls  |
|                                                                | ELITE is responsible for      the initiation, execution and follow-up for any Product      recall.  ELITE      must communicate and issue the recall in accordance with federal      regulations.  ELITE must notify PRECISION DOSE within 24      hours of a decision to recall  |
|                                                                | 5.7.1.1         PRECISION DOSE is obligated to report any potential problems      or issues with the Product to ELITE within 24 hours      from the time such information is known.    |
|                                                                | 5.7.2         Field      Alerts  |
|                                                                | ELITE shall notify PRECISION DOSE      immediately of any failure that meets Field Alert Report criteria.      ELITE shall notify      the District Office within three (3) working days of the failure for ELITE      labeled Product.  PRECISION DOSE is      obligated to report any potential problems or issues with the Product to      ELITE within 24      hours from the time such information is known.  |

----

|                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|---------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                | 5.7.3         Complaints                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                | In      the event that a customer complaint is received by PRECISION DOSE, written      notification shall be provided to ELITE within 48 hours of      receipt. ELITE is      responsible for the handling, administration, investigation, corrective      actions and response to customers for all complaints.                                                                                                                                                                                                  |
|                                                                | 5.7.3.1 In the event an      adverse experience is reported to or received by PRECISION DOSE, written      notification including all known patient and product information shall be      provided to ELITE      within 24 hours of receipt by PRECISION      DOSE.  ELITE is responsible for maintaining the      pharmacovigillence program including adverse experience reporting,      regulatory reporting and follow-up reports within the established      timelines of the federal regulations.  |
| 5.8         Change      Control and Deviations  |
|                                                                | 5.8.1         Change      Control                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|                                                                | ELITE shall maintain a change contorl program and      providePRECISION DOSEnotification of their intention to make      changes to the formulation, components, manufacturing processes, test      methods or specifications, or labeling.                                                                                                                                                                                                                                                                        |
|                                                                | 5.8.2         Deviations                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                                                | ELITE shall record any deviations from      the manufacturing process and/or testing of the Product(s) in the      batch/testing records and clearly document any such deviations related to      finished goods specifications.                                                                                                                                                                                                                                                                                   |
|                                                                | 5.8.3    Validation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|                                                                | Any      changes to validated equipment, systems, processes or test methods shall      be assessed and evaluated as to the impact on the Product and the approved      application. ELITE      shall communicate changes that affect the approved application to      PRECISION      DOSE.  ELITE is responsible for maintaining all      equipment, systems, processes and test methods in a validated      state.                                                                                      |
| 5.9         Annual      Product Review          |
|                                                 | ELITE is responsible for      performing and providing an Annual Product Review (APR) on the anniversary      date for each manufactured Product.                                                                                                                                                                                                                                                                                                                                                                  |
| 6.0    Miscellaneous                            |
| 6.1         Communications                      |
|                                                                | All      notices and communications concerning this Exhibit  C, or any of      the provisions contained herein, shall be addressed to the responsible      functionaries of the Parties respectively assigned designated Appendix      1.                                                                                                                                                                                                                                                                |

----

| IN WITNESS WHEREOF, the      parties hereto have caused this Agreement to be executed, as of the date      first above written, by their duly authorized    representatives |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ELITE      PHARMACEUTICALS, INC.                                                                                                                                                                                                                                                                                                                                                                                                               |   | PRECISION      DOSE INC.                                                                                                                                                                                                                                                                                                                                                                            |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| By:                                                                         |   | By:                                                                 |
| Name:      Chris Dick                                                                                                                                                                                                                                                                                                                                                                                                                               |   | Name:      Robert Koopman                                                                                                                                                                                                                                                                                                                                                                      |
| Title:   President                                                                                                                                                                                                                                                                                                                                                                                                                   |   | Title:   President                                                                                                                                                                                                                                                                                                                                                                   |

----

| APPENDIX      1 |
|-----------------|

| ELITE      Pharmaceuticals, Inc.               |
|-----------------------------------------------------|
| Primary      Contact                                |   | QA      Contact |   | Regulatory      Contact |
|  Name      Chris Dick                          |   |  Name      Mimi Park  |   |  Name  Mimi      Park |
|  Title  President                    |   |  Title  Head      of Quality Assurance & Compliance |   |  Title   Head      of Quality Assurance & Compliance |
|  Telephone      Number  201-367-7860 |   |  Telephone      Number  201-367-7854 |   |  Telephone      Number  201-367-7854 |

| PRECISION      DOSE, Inc                                |
|--------------------------------------------------------------|
| Primary      Contact                                         |   | QA      Contact |   | Regulatory      Contact |
| Name:  Melissa      Edge                           |   | Name:  Mark      Franzen |   | Name:  Mary      Zieker |
|  Title      Vice President of Procurement               |   |  Title  Director,      Quality Assurance |   |  Title      Vice President of Quality and Regulatory |
|  Telephone      Number  815-624-8523 ext. 218 |   |  Telephone      Number  815-624-8523 ext. 226 |   |  Telephone      Number  815-624-8523 ext.208 |

----

| APPENDIX      2 |
|-----------------|

| ·   | Hydromorphone      8 mg, 4 mg and 2mg Tablets – 100’s and500’s |
|--------------------|----------------------------------------------------------------------------------|

| ·   | Naltrexone      50 mg Tablets – 30’s and 100’s |
|--------------------|------------------------------------------------------------------|

| ·   | {***} {***}      mg Tablets – 100’s and 1000’s |
|--------------------|-----------------------------------------------------------------------|

| ·   | {***} {***}      mg and {***} mg Capsules – 100’s and1000’s |
|--------------------|-----------------------------------------------------------------------------------------|

----